Mubadala Investment Company in EQRx, Inc.
Announced. First disclosed August 6, 2021, in an issuer or fund release (source).
- Investor
- Mubadala Investment Company (United Arab Emirates)
- Investor as named in source
- Mubadala Investment Company and its asset management subsidiary, Mubadala Capital
- Target
- EQRx, Inc.
- Target country
- United States
- Sector
- Health and Life Sciences
- First disclosed
- August 6, 2021, Issuer or fund release
- Amount
- Not stated
- Stake at first disclosure
- Not stated
- Source text
Participants in the PIPE include leading institutional life science, growth and strategic investors that include Fidelity Management & Research Company LLC, Franklin Templeton, Invus, Rock Springs Capital, Bain Capital Life Sciences, BVF Partners L.P., Boxer Capital, LLC, Avidity Partners, Andreessen Horowitz (a16z), Mubadala Investment Company and its asset management subsidiary, Mubadala Capital, Verily and strategic partners spanning the healthcare ecosystem of integrated delivery networks, health insurers, health systems and therapeutic developers.
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| August 6, 2021 | CM Life Sciences III Inc. release | Not applicable | View |
Cite: Middle East Forum, “Mubadala Investment Company in EQRx, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/mubadala-eqrx-inc/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.